Trial Profile
A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (Anaplastic Gliomas and Glioblastoma)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 07 Jun 2017 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Interim results (n=26) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 16 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.